Incorporation of Countervail June 20, 2007 • admin • General News With the intent of protecting military and civilian personnel from chemical threat agents, Countervail was formed and incorporated in June 2007 as a Delaware corporation. Related News US Parent Patent awarded for use of galantamine as Method of Treating Organophosphorus Poisoning. February 2, 2011 Countervail’s principal investigator presents at 2009 NINDS CounterACT meeting in Washington, DC. Dr. Edson Albuquerque presents additional data on galantamine’s effectiveness in preserving survival and prevention of neural cell damage from nerve agent exposure. April 14, 2009